Ausgabe 2/2018
Inhalt (11 Artikel)
Immunotherapy in Breast Cancer: the New Frontier
Zishuo I. Hu, Heather L. McArthur
HER2 Activating Mutations in Estrogen Receptor Positive Breast Cancer
Elisa M. Murray, Mathew A. Cherian, Cynthia X. Ma, Ron Bose
Prepectoral Breast Reconstruction
Deepa Bhat, Halley Darrach, Justin M. Sacks
Optimizing Surgical Treatment for Phyllodes Tumor
Kai Chen, Yanbo Chen, Paul Cartwright, Lisa Jacobs
Choosing Wisely: Optimizing Routine Workup for the Newly Diagnosed Breast Cancer Patient
Spencer W. Trooboff, Ravinder Kang, Julie Margenthaler, Sandra L. Wong
Managing Patient with Mutations in PALB2, CHEK2, or ATM
Francisco Acevedo, Zhengyi Deng, Victor D. Armengol, Kevin Hughes
Recent Trends in Local-Regional Recurrence Rates: Implications for Therapeutic Intervention
Vishnu Prasath, Mehran Habibi
Estimating Contralateral Breast Cancer Risk
Maureen O’Donnell
Individualizing Local-Regional Therapy of Breast Cancer in the Elderly
Apoorve Nayyar, Trevor A. Jolly, Ellen T. Jones, Kandace P. McGuire, Hyman B. Muss, Kristalyn K. Gallagher
Local-Regional Evaluation and Therapy: Maximizing Margin-Negative Breast Cancer Resection Rates on the First Try
Lacey Stelle, Jennifer Wellington, Wen Liang, Robert Buras, Lorraine Tafra
Breast Density and the Importance of Supplemental Screening
Brian Weber, Jody Hayes, W. Phil Evans